Beneficial effects of intravenous pamidronate treatment in children with osteogenesis imperfecta under 24 months of age

K Kusumi, R Ayoob, SA Bowden, S Ingraham… - Journal of bone and …, 2015 - Springer
Osteogenesis imperfecta (OI) is an inherited disorder characterized by bone fragility and low
bone mass. Low bone density and fracture is a cause of morbidity. Limited data exists on …

Beneficial effects of intravenous pamidronate treatment in children with osteogenesis imperfecta under 24 months of age.

K Kusumi, R Ayoob, S Bowden… - Journal of Bone & …, 2015 - search.ebscohost.com
Osteogenesis imperfecta (OI) is an inherited disorder characterized by bone fragility and low
bone mass. Low bone density and fracture is a cause of morbidity. Limited data exists on …

Beneficial effects of intravenous pamidronate treatment in children with osteogenesis imperfecta under 24 months of age.

K Kusumi, R Ayoob, SA Bowden… - Journal of Bone and …, 2014 - europepmc.org
Osteogenesis imperfecta (OI) is an inherited disorder characterized by bone fragility and low
bone mass. Low bone density and fracture is a cause of morbidity. Limited data exists on …

Beneficial effects of intravenous pamidronate treatment in children with osteogenesis imperfecta under 24 months of age

K Kusumi, R Ayoob, SA Bowden… - Journal of bone …, 2015 - pubmed.ncbi.nlm.nih.gov
Osteogenesis imperfecta (OI) is an inherited disorder characterized by bone fragility and low
bone mass. Low bone density and fracture is a cause of morbidity. Limited data exists on …

Beneficial effects of intravenous pamidronate treatment in children with osteogenesis imperfecta under 24 months of age

K Kusumi, R Ayoob, SA Bowden, S Ingraham… - Journal of Bone and …, 2015 - infona.pl
Osteogenesis imperfecta (OI) is an inherited disorder characterized by bone fragility and low
bone mass. Low bone density and fracture is a cause of morbidity. Limited data exists on …

Beneficial effects of intravenous pamidronate treatment in children with osteogenesis imperfecta under 24 months of age

K Kusumi, R Ayoob, SA Bowden… - Journal of Bone …, 2015 - ohiostate.elsevierpure.com
Osteogenesis imperfecta (OI) is an inherited disorder characterized by bone fragility and low
bone mass. Low bone density and fracture is a cause of morbidity. Limited data exists on …

Beneficial effects of intravenous pamidronate treatment in children with osteogenesis imperfecta under 24 months of age

K Kusumi, R Ayoob, SA Bowden… - Journal of Bone and …, 2015 - search.proquest.com
Osteogenesis imperfecta (OI) is an inherited disorder characterized by bone fragility and low
bone mass. Low bone density and fracture is a cause of morbidity. Limited data exists on …

[引用][C] Beneficial effects of intravenous pamidronate treatment in children with osteogenesis imperfecta under 24 months of age

K Kusumi, R Ayoob, SA Bowden, S Ingraham… - Journal of bone and …, 2015 - Springer